This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Panetta Statement On Passing Of Duane Roth

SAN DIEGO, Aug. 4, 2013 /PRNewswire/ -- Joe Panetta, president and CEO of BIOCOM, released the following statement upon news of the passing of Duane Roth, President and CEO of CONNECT:

"I speak for the BIOCOM board, staff, and the entire BIOCOM family in saying the life science industry has lost one of its most devoted champions.  Duane's passion for the industry first as a company executive (with Alliance Pharmaceutical) and later as CONNECT's President and CEO was unwavering.  His contributions to San Diego are not limited to the life science industry, and his loss will be felt throughout our community."

(Logo:  http://photos.prnewswire.com/prnh/20130228/LA69104LOGO)

"Personally, I will deeply miss Duane as a friend, colleague, and confidant.  Our lives were intertwined not only professionally but socially and casually as well.  Karin and I extend our deepest sympathies to Renee and the entire Roth family."

Duane Roth was a founding member of the BIOCOM Board of Directors and is the only person to have served two terms as BIOCOM board chair, in 1996-97 and 2004-05.  In 2010, Roth was given the highest honor BIOCOM can bestow on a board member, that of Life Director, a position reserved only to those who have distinguished themselves in service at the highest levels to BIOCOM and the Southern California life science community.

SOURCE BIOCOM
Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

DOW 17,757.91 +138.40 0.79%
S&P 500 2,075.75 +12.64 0.61%
NASDAQ 5,008.5630 +21.6960 0.44%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs